Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CloverASX:CLV +7.64%60 Market Cap is A$141.11 Mil as of Jul. 16, 2026. GuruFocus rates ASX:CLV with a GF Score™ of 60/100 and a GF Value™ of A$0.76 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 2,042 Consumer Packaged Goods companies, Clover ranks worse than 52.25% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Clover's share price for the quarter that ended in Jan. 2026 was A$0.78. Clover's Shares Outstanding (EOP) for the quarter that ended in Jan. 2026 was 167.00 Mil. Therefore, Clover's market cap for the quarter that ended in Jan. 2026 was A$130.26 Mil.
Clover's quarterly market cap
increased
from Jan. 2025 (A$65.13 Mil) to Jul. 2025 (A$92.68 Mil) and
increased
from Jul. 2025 (A$92.68 Mil) to Jan. 2026 (A$130.26 Mil).
Clover's annual market cap
declined
from Jul. 2023 (A$182.03 Mil) to Jul. 2024 (A$81.83 Mil) but then
increased
from Jul. 2024 (A$81.83 Mil) to Jul. 2025 (A$92.68 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Clover's Enterprise Value for Today is A$132.11 Mil.
Clover (ASX:CLV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Clover Market Cap Related Terms
Clover Market Cap Historical Data
* Premium members only.
The historical data trend for Clover's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Clover's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Clover's Market Cap distribution charts can be found below:
* The bar in red indicates where Clover's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Clover's Market Cap for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover (ASX:CLV) has a Market Cap of A$141.11 Mil as of Jul. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Clover and its competitors. According to the industry distribution chart, Clover ranks #1067 out of 2042 companies in the Consumer Packaged Goods industry, placing it in the top 52.3%.
Is Clover's Market Cap too high?
Clover's current Market Cap is A$141.11 Mil. Based on the distribution chart, Clover ranks #1067 out of 2042 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Clover has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Clover ranks #1067 out of 2042 companies for Market Cap. This places Clover in the lower half of its industry. The industry median Market Cap is 104.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 104.09, based on 2,042 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Clover and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 104.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover's current Market Cap is A$141.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover stock overvalued right now?
Based on GuruFocus' analysis, Clover (ASX:CLV) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.76, compared to a current price of A$0.85 — trading 11.2% above its estimated fair value. The current Market Cap is A$141.11 Mil. Clover's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Clover (ASX:CLV), the current Market Cap is A$141.11 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover (ASX:CLV) Overvalued in 2026?
Based on GuruFocus' analysis, Clover stock appears to be overvalued.
The current stock price of A$0.85 is trading 11.2% above its estimated GF Value™ of A$0.76.
GuruFocus considers Clover to be Modestly Overvalued.
Key valuation signals for ASX:CLV:
Market Cap: A$141.11 Mil
GF Value™: A$0.76 vs. price of A$0.85 (11.2% above fair value)
No single metric tells the full story. See the ASX:CLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.
60GF Score
Get the complete analysis for ASX:CLV
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CLV has been successfully added to your 
